Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 3 (2016) EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS Abstract  similar documents
N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova
"... Early health technologies assessment (HTA) is a form of HTA, which takes place at early stages ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
"... ) is the national health technology assessment (HTA) authority in charge of the reimbursement and formulary-listing ..."
 
Vol 6, No 2 (2013) HTA CORE MODEL Abstract  similar documents
R. I. Yagudina, T. Yu. Nor, A. D. Sevostyanov
"... and reporting methods. The HTA Core Model aim is to create a single database on health technologies, which might ..."
 
Vol 12, No 2 (2019) Organizational structure and funding of health technology assessment agencies around the world Abstract  similar documents
G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak
"... Aim: analyze the structure and funding of health technology assessment (HTA) agencies abroad ..."
 
Vol 11, No 3 (2018) The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia Abstract  similar documents
V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina
"... the principles of health technologies assessment (HTA) and the reimbursement strategies in Russia have been put ..."
 
Vol 5, No 3 (2012) DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS Abstract  similar documents
F. A. Khabirov, D. Kh. Shakirova, O. A. Dun, T. I. Khaibullin
"... in the present research is shown that using information and computer technologies can automate ..."
 
Vol 6, No 4 (2013) Using indirect comparisons in pharmacoeconomic examination Abstract  similar documents
Yu. E. Balykina, A. S. Kolbin
"... Health technology assessment is a fundamental tool while choosing the most cost- and clinical ..."
 
Vol 7, No 3 (2014) THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT Abstract  similar documents
V. I. Ignatyeva, M. V. Avxentyeva
"... for the health technology assessment. Materials and methods. Based on the results of studying foreign ..."
 
Vol 9, No 1 (2016) PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS Abstract  similar documents
O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina
"... of hospitalization replacement technologies within 8 months at 57 patients amounted to 2 072 934,1 rbl ..."
 
Vol 6, No 2 (2013) COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
"... лечении ВИЧ�инфекции � Базовая модель оценки технологий здравоохранения � VII конгресс с международным ..."
 
Vol 7, No 4 (2014) MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES Abstract  similar documents
M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya
"... alternative medical organizational technologies, taking into account the continuing incapacity of the patient ..."
 
Vol 8, No 2 (2015) PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS Abstract  similar documents
Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova
"... по оценке технологий в здравоохранении», Москва 2 ФГБОУ ВПО «Российская академия народного ..."
 
Vol 11, No 4 (2018) International experience in determining the cost-effectiveness thresholds Abstract  similar documents
T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky
"... the presence of HTA systems. The CeT is expressed as additional cost per unit of incremental health benefit ..."
 
Vol 7, No 1 (2014) CLINICAL AND ECONOMIC ANALYSIS IN ASSESSMENT OF HEALTH CARE TECHNOLOGIES IN HEALTH CARE INSTITUTIONS Abstract  similar documents
I. B. Gaykovaya, A. T. Burbello, A. I. Ermakov, A. S. Fedorenko, T. V. Vavilova, M. V. Komok
"... � Клинико экономический анализ в оценке технологий здравоохранения в лечебно профилактическом ..."
 
Vol 11, No 4 (2018) “Near miss” in obstetrics: classification, evaluation, and significance for healthcare technology assessment Abstract  similar documents
I. K. Мamontova, T. V. Shevlyakovа, E. I. Petrova
"... the “near miss” cases for the purposes of healthcare technologies asessment. The paper also discusses ..."
 
Vol 11, No 3 (2018) Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies Abstract  similar documents
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov
"... for medical technologies in the Russian Federation, determined by estimating the shadow budget price ..."
 
Vol 7, No 3 (2014) ECONOMIC JUSTIFICATION FOR TELEHEALTH TECHNOLOGY USE FOR PREVENTIVE MEDICAL EXAMINATION OF THE POPULATION IN REMOTE REGIONS Abstract  similar documents
D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky
"... in this article we analysis possibility of application telemedical technologies for regular ..."
 
Vol 11, No 3 (2018) Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them Abstract  similar documents
S. V. Ponomarenko
"... technology for its production, the marketing aspects and the prospective of enzyme therapy are addressed ..."
 
Vol 7, No 3 (2014) PROBLEMS OF OUTCOMES CHOICE FOR THE ASSESSMENT OF REHABILITATION PROGRAMS EFFICIENCY IN PATIENTS AFTER STROKE AND CRANIOCEREBRAL INJURY Abstract  similar documents
V. S. Dombrovskiy, V. V. Omelyanovskiy
"... for the efficacy evaluation of such technology.  ..."
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract  similar documents
L. S. Melnikova
"... legislative environment. The role of medical technologies evaluation system is regarded as one of the elements ..."
 
Vol 11, No 2 (2018) Introduction of medical products into healthcare practice and costs reimbursement: European experience Abstract  similar documents
V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii
"... . The comprehensive assessment of new technologies will provide for the transparency of the proposed system. ..."
 
Vol 6, No 3 (2013) COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
"... – затраты на медицинскую технологию, руб.; Ef – параметр эффективности медицинской технологии. Аналогичным ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation Abstract  similar documents
A. Yu. Kulikov, L. A. Komarov
"... , инвалидизация, смертность, повторные инсульты, неврология, оценка технологий здравоохранения, ноотропы ..."
 
Vol 9, No 1 (2016) PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT Abstract  similar documents
N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova
"... severe. It is a childhood-onset disease that leads to early disability and mental retardation ..."
 
Vol 11, No 1 (2018) Presepsin as a sepsis biomarker Abstract  similar documents
K. A. Trunova
"... in a combination with other markers of sepsis. Considering that presepsin has a good potential of detecting early ..."
 
Vol 6, No 3 (2013) ECONOMIC EVALUATION OF THE EFFECTIVENESS OF LOW MOLECULAR WEIGHT HEPARIN AND INTERMITTENT PNEUMATIC COMPRESSION IN WOMEN IN A CYCLE OF IN VITRO FERTILIZATION Abstract  similar documents
A. P. Momot, I. V. Molchanova, N. A. Semenova, O. P. Tomilina, E. A. Elykomov, O. G. Borisova
"... To solve the problem of infertility in the world assisted reproductive technologies (ART ..."
 
Vol 9, No 3 (2016) CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov
"... as concomitant drug to standard therapy (scenario 2) and early administration of Lacosamide as the first ..."
 
Vol 7, No 1 (2014) PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY Abstract  similar documents
D. V. Blinov
"... evaluation and health technology assessment in management of patients with neurological diseases ..."
 
Vol 8, No 1 (2015) BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"... of economic efficiency and availability of technology was carried also out to be allowing to estimate ..."
 
Vol 9, No 1 (2016) REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES Abstract  similar documents
K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... to expenditure growth have focused on outpatient pharmaceuticals, evaluation of medical technologies and reducing ..."
 
Vol 10, No 3 (2017) Evaluation of economic damage from multiple sclerosis in the city of Ufa, Russia Abstract  similar documents
E. V. Ivanova, K. Z. Bachtiyarova
"... system due to its early onset, increasing life expectancy of the patients, and the use of costly ..."
 
Vol 10, No 3 (2017) Review of the current approaches to the assessment of the drug innovative potential worldwide Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits
 
Vol 6, No 1 (2013) PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk
"... . The pharmacoeconomic study results have shown, that a CFP10-ESAT6 is dominant technology from «cost-effectiveness ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"...  rational medical technology. ..."
 
Vol 9, No 4 (2016) COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY Abstract  similar documents
V. S. Dombrovskiy, G. R. Khachatryan
"... отношении скрининга состояния на ранней стадии, когда существуют эффективные меры по пре- дотвращению ..."
 
Vol 11, No 1 (2018) Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia Abstract  similar documents
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
"... with schizophrenia, and a  subsequent pharmacoeconomic modeling. Two medical technologies were evaluated ..."
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia Abstract  similar documents
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
"... , and a subsequent pharmacoeconomic modeling. Two medical technologies were evaluated and compared: treatment ..."
 
Vol 9, No 2 (2016) METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY Abstract  similar documents
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov
"... при Президенте Российской Федерации», Москва 3 АНО «Национальный центр по оценке технологий ..."
 
Vol 11, No 4 (2018) Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease Abstract  similar documents
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev
"... and CNS complications. According to the currently available information, the early start of enzyme ..."
 
Vol 9, No 3 (2016) HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE Abstract  similar documents
A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
"... Том 9 Том 8 2016 � Оплата новых дорогостоящих технологий в здравоохранении на основе соглашений ..."
 
Vol 8, No 4 (2015) THE COST OF NUTRITION ALTERNATIVES FOR PREMATURE INFANTS IN RUSSIA Abstract  similar documents
K. V. Gerasimova, M. V. Avxentyeva, I. A. Belyaeva
"... .F., Barr I. et al. Multicentre trial on feeding low birthweight infants: effects of diet on early growth ..."
 
Vol 10, No 4 (2017) PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... and 2 do not exceed one GDP per capita, and the technologies are cost-effective. Conclusion. In both ..."
 
Vol 9, No 4 (2016) REVIEW OF PRACTICE AND POSSIBLE DIRECTIONS OF CONCRETIZATION THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS Abstract  similar documents
D. V. Fedyaev, L. S. Melnikova, V. I. Ignatyeva
"... умерших в возрасте 0-17 лет; – доля впервые выявленных случаев туберкулеза в ранней ста- дии в общем ..."
 
Vol 5, No 2 (2012) VI Конгресс с международным участием «Развитие фармакоэкономики и фармакоэпидемиологии в Российской Федерации» Abstract  similar documents
"... оценка технологий здравоохранения (HealthTechnologyAssessment – HTA). Появилось понимание необходимости ..."
 
Vol 8, No 2 (2015) ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA Abstract  similar documents
Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov
"... технологий в здравоохранении», Москва 4 ГБОУ ВПО «Первый МГМУ имени И.М. Сеченова» Минздрава России ..."
 
Vol 7, No 4 (2014) APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES Abstract  similar documents
V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova
"... таких ЛП и сложностью технологии их изготовления [6]. Экспертным советом по здравоохранению Комитета ..."
 
Vol 8, No 2 (2015) REVIEW OF THE INTERNATIONAL PRACTICE OF COST-SHARING MECHANISM IN NATIONAL HEALTH CARE SYSTEMS Abstract  similar documents
Natalia Nikolayevna Sisigina, Vitalii Vladimirovich Omel'yanovskii, Nikolay Alexandrovich Avxentyev
"... сохранить достаточно высокую финансо- вую доступность медицинской помощи. В отличие от ранней прак- тики ..."
 
Vol 6, No 1 (2013) CHIEF EDITOR`S COLUMN Abstract  similar documents
R. I. Yagudina
"... году в фокусе внимания профессиональной отрас- ли оказалось такое направление как «Оценка Технологий ..."
 
1 - 50 of 145 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)